https://www.rtn.asia Fri, 09 Feb 2024 02:21:51 +0000 en hourly 1 https://wordpress.org/?v=6.7 https://www.rtn.asia/wp-content/uploads/2023/09/cropped-logo-square-32x32.png https://www.rtn.asia 32 32 https://www.rtn.asia/n-n/55218/biocon-receives-update-from-usfda-on-bevacizumab-biosimilar-approval Fri, 09 Feb 2024 02:21:50 +0000 https://www.rtn.asia/?p=55218 https://www.rtn.asia/s-k/55180/hester-biosciences-sees-40-fall-in-pat-on-lower-demand-for-goat-pox-vaccine Fri, 02 Feb 2024 07:42:25 +0000 https://www.rtn.asia/?p=55180 https://www.rtn.asia/s-k/54711/canadas-apotex-files-118-mn-arbitration-against-indias-panacea-biotec Thu, 05 Oct 2023 16:26:28 +0000 https://www.rtn.asia/?p=54711 https://www.rtn.asia/n-n/54705/sun-pharma-invests-rs-32-cr-in-two-healthcare-startups Thu, 05 Oct 2023 16:05:12 +0000 https://www.rtn.asia/?p=54705 https://www.rtn.asia/s-k/54625/indian-pharma-sees-moderation-in-us-generic-sales-growth-in-august-2023 Tue, 03 Oct 2023 08:16:41 +0000 https://www.rtn.asia/?p=54625 https://www.rtn.asia/n-n/54533/bidding-for-biogens-biosimilars-intas-best-placed-over-samsung-dr-reddys Tue, 26 Sep 2023 08:47:37 +0000 https://www.rtn.asia/?p=54533 https://www.rtn.asia/s-k/54489/indian-pharma-sales-to-see-pick-up-in-second-half-of-the-year-analysts Fri, 15 Sep 2023 05:58:18 +0000 https://www.rtn.asia/?p=54489 https://www.rtn.asia/s-k/54351/rising-generic-threat-in-india-not-reflected-in-pharma-valuations-kotak-institutional Tue, 05 Sep 2023 04:57:56 +0000 https://www.rtn.asia/?p=54351 https://www.rtn.asia/n-n/54323/systematix-puts-a-buy-on-pfizer-india-on-drug-strong-pipeline Sun, 03 Sep 2023 05:07:22 +0000 https://rtn.asia/?p=54323 https://www.rtn.asia/t-t/53785/zydus-cadila-gets-usfda-nod-for-acadias-parkinsons-drug Wed, 22 Dec 2021 07:17:42 +0000 https://ultra.news/?p=53785